Cargando…
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease
Recently, a fully automated instrument for the detection of the Cerebrospinal Fluid (CSF) biomarker for Alzheimer’s disease (AD) (low concentration of Amyloid-beta 42 (Aβ42), high concentration of total tau (T-tau) and Phosphorylated-tau (P-tau181)), has been implemented, namely CLEIA. We conducted...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599653/ https://www.ncbi.nlm.nih.gov/pubmed/36289929 http://dx.doi.org/10.3390/biomedicines10102667 |
_version_ | 1784816646852968448 |
---|---|
author | Arcaro, Marina Fenoglio, Chiara Serpente, Maria Arighi, Andrea Fumagalli, Giorgio G. Sacchi, Luca Floro, Stefano D’Anca, Marianna Sorrentino, Federica Visconte, Caterina Perego, Alberto Scarpini, Elio Galimberti, Daniela |
author_facet | Arcaro, Marina Fenoglio, Chiara Serpente, Maria Arighi, Andrea Fumagalli, Giorgio G. Sacchi, Luca Floro, Stefano D’Anca, Marianna Sorrentino, Federica Visconte, Caterina Perego, Alberto Scarpini, Elio Galimberti, Daniela |
author_sort | Arcaro, Marina |
collection | PubMed |
description | Recently, a fully automated instrument for the detection of the Cerebrospinal Fluid (CSF) biomarker for Alzheimer’s disease (AD) (low concentration of Amyloid-beta 42 (Aβ42), high concentration of total tau (T-tau) and Phosphorylated-tau (P-tau181)), has been implemented, namely CLEIA. We conducted a comparative analysis between ELISA and CLEIA methods in order to evaluate the analytical precision and the diagnostic performance of the novel CLEIA system on 111 CSF samples. Results confirmed a robust correlation between ELISA and CLEIA methods, with an improvement of the accuracy with the new CLEIA methodology in the detection of the single biomarkers and in their ratio values. For Aβ42 regression analysis with Passing–Bablok showed a Pearson correlation coefficient r = 0.867 (0.8120; 0.907% 95% CI p < 0.0001), T-tau analysis: r = 0.968 (0.954; 0.978% 95% CI p < 0.0001) and P-tau181: r = 0.946 (0.922; 0.962 5% 95% CI p < 0.0001). The overall ROC AUC comparison between ROC in ELISA and ROC in CLEIA confirmed a more accurate ROC AUC with the new automatic method: T-tau AUC ELISA = 0.94 (95% CI 0.89; 0.99 p < 0.0001) vs. AUC CLEIA = 0.95 (95% CI 0.89; 1.00 p < 0.0001), and P-tau181 AUC ELISA = 0.91 (95% CI 0.85; 0.98 p < 0.0001) vs. AUC CLEIA = 0.98 (95% CI 0.95; 1.00 p < 0.0001). The performance of the new CLEIA method in automation is comparable and, for tau and P-tau181, even better, as compared with standard ELISA. Hopefully, in the future, automation could be useful in clinical diagnosis and also in the context of clinical studies. |
format | Online Article Text |
id | pubmed-9599653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95996532022-10-27 A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease Arcaro, Marina Fenoglio, Chiara Serpente, Maria Arighi, Andrea Fumagalli, Giorgio G. Sacchi, Luca Floro, Stefano D’Anca, Marianna Sorrentino, Federica Visconte, Caterina Perego, Alberto Scarpini, Elio Galimberti, Daniela Biomedicines Article Recently, a fully automated instrument for the detection of the Cerebrospinal Fluid (CSF) biomarker for Alzheimer’s disease (AD) (low concentration of Amyloid-beta 42 (Aβ42), high concentration of total tau (T-tau) and Phosphorylated-tau (P-tau181)), has been implemented, namely CLEIA. We conducted a comparative analysis between ELISA and CLEIA methods in order to evaluate the analytical precision and the diagnostic performance of the novel CLEIA system on 111 CSF samples. Results confirmed a robust correlation between ELISA and CLEIA methods, with an improvement of the accuracy with the new CLEIA methodology in the detection of the single biomarkers and in their ratio values. For Aβ42 regression analysis with Passing–Bablok showed a Pearson correlation coefficient r = 0.867 (0.8120; 0.907% 95% CI p < 0.0001), T-tau analysis: r = 0.968 (0.954; 0.978% 95% CI p < 0.0001) and P-tau181: r = 0.946 (0.922; 0.962 5% 95% CI p < 0.0001). The overall ROC AUC comparison between ROC in ELISA and ROC in CLEIA confirmed a more accurate ROC AUC with the new automatic method: T-tau AUC ELISA = 0.94 (95% CI 0.89; 0.99 p < 0.0001) vs. AUC CLEIA = 0.95 (95% CI 0.89; 1.00 p < 0.0001), and P-tau181 AUC ELISA = 0.91 (95% CI 0.85; 0.98 p < 0.0001) vs. AUC CLEIA = 0.98 (95% CI 0.95; 1.00 p < 0.0001). The performance of the new CLEIA method in automation is comparable and, for tau and P-tau181, even better, as compared with standard ELISA. Hopefully, in the future, automation could be useful in clinical diagnosis and also in the context of clinical studies. MDPI 2022-10-21 /pmc/articles/PMC9599653/ /pubmed/36289929 http://dx.doi.org/10.3390/biomedicines10102667 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Arcaro, Marina Fenoglio, Chiara Serpente, Maria Arighi, Andrea Fumagalli, Giorgio G. Sacchi, Luca Floro, Stefano D’Anca, Marianna Sorrentino, Federica Visconte, Caterina Perego, Alberto Scarpini, Elio Galimberti, Daniela A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease |
title | A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease |
title_full | A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease |
title_fullStr | A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease |
title_full_unstemmed | A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease |
title_short | A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease |
title_sort | novel automated chemiluminescence method for detecting cerebrospinal fluid amyloid-beta 1-42 and 1-40, total tau and phosphorylated-tau: implications for improving diagnostic performance in alzheimer’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599653/ https://www.ncbi.nlm.nih.gov/pubmed/36289929 http://dx.doi.org/10.3390/biomedicines10102667 |
work_keys_str_mv | AT arcaromarina anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT fenogliochiara anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT serpentemaria anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT arighiandrea anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT fumagalligiorgiog anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT sacchiluca anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT florostefano anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT dancamarianna anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT sorrentinofederica anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT viscontecaterina anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT peregoalberto anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT scarpinielio anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT galimbertidaniela anovelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT arcaromarina novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT fenogliochiara novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT serpentemaria novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT arighiandrea novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT fumagalligiorgiog novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT sacchiluca novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT florostefano novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT dancamarianna novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT sorrentinofederica novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT viscontecaterina novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT peregoalberto novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT scarpinielio novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease AT galimbertidaniela novelautomatedchemiluminescencemethodfordetectingcerebrospinalfluidamyloidbeta142and140totaltauandphosphorylatedtauimplicationsforimprovingdiagnosticperformanceinalzheimersdisease |